Table 3 Univariate analysis of patient characteristics
Parameters | No of patients with ≥ G2 RP (%) | No of patients with G0-1 RP (%) | p value |
|---|---|---|---|
Age | 0.074 | ||
< 75 years old | 1 (11) | 25 (45) | |
≥ 75 | 8 (89) | 31 (55) | |
Sex | 0.392 | ||
Man | 6 (67) | 45 (80) | |
Female | 3 (33) | 11 (20) | |
PS | 0.458 | ||
0 or 1 | 8 (89) | 53 (95) | |
2 | 1 (11) | 3 (5) | |
Location of primary tumor | 0.706 | ||
Upper or Middle lobe | 7 (78) | 36 (64) | |
Lower lobe | 2 (22) | 20 (36) | |
Clinical Stage | 1.000 | ||
II | 5 (56) | 32 (57) | |
III | 4 (44) | 24 (43) | |
Total dose | 1.000 | ||
≤ 72 Gy RBE | 8 (89) | 46 (82) | |
> 72 Gy RBE | 1 (11) | 10 (18) | |
Chemotherapy | 0.187 | ||
Yes | 0 | 14 (25) | |
No | 9 (100) | 42 (75) | |
Brinkman Index | 1.000 | ||
< 600 | 3 (33) | 19 (34) | |
≥ 600 | 6 (67) | 37 (66) | |
Pulmonary emphysema | 0.191 | ||
Yes | 0 | 12 (21) | |
No | 9 (100) | 44 (79) |